Extended Data Fig. 5: IDI curve analysis of different approaches for biopsy-proven CSPCa diagnosis.
From: An MRI–pathology foundation model for noninvasive diagnosis and grading of prostate cancer
a) Comparison between PI-RADS and MRI-PTPCa. b) Comparison between PI-RADS and MRI-PTPCa in PI-RADS Score=3 subgroup. c) Comparison between PI-RADS and MRI-PTPCa in PI-RADS score≥3 subgroup. d) Comparison between PI-RADS and MRI-PTPCa in PI-RADS score<3 subgroup. e) Comparison between PI-RADS and MRI-PTPCa in PCa subgroup. The confidence intervals were computed using a 1000-times bootstrapping strategy with replacement. Error bars represent the error between the NRI value of the prediction model and the reference. Error bands represent IDI value.
